Press Release
AimedBio and GC Cell Partner to Co-develop Next-Generation CAR-NK Cell Therapy
2022.07.29
- - AimedBio and GC Cell have entered into a collaboration agreement to jointly develop a CAR-NK cell therapy.
- - The partnership aims to generate a CAR-NK therapeutic candidate using AimedBio’s AMB015 antibody, which specifically binds to a cancer-specific target protein.
- - Through this collaboration, AimedBio expects to expand its antibody-based therapeutic portfolio beyond antibody-drug conjugates (ADCs) into the field of cell therapies.
Link: http://www.biospectator.com/view/news_view.php?varAtcId=16852